Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$7.42
-1.00%
Mkt Cap $841.74M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+129.3%
Consensus $17.00 vs current $7.42
NASDAQ·Healthcare·Biotechnology
$7.42
-1.00%
Mkt Cap $841.74M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+129.3%
Consensus $17.00 vs current $7.42